Help
RSS
API
Feed
Maltego
Contact
Domain > www.erivedge.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2017-02-01
52.8.1.125
(
ClassC
)
2019-09-23
52.9.196.166
(
ClassC
)
2024-08-31
104.18.6.49
(
ClassC
)
2024-09-10
104.18.7.49
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyDate: Sat, 31 Aug 2024 22:03:04 GMTContent-Type: text/htmlContent-Length: 167Connection: keep-aliveCache-Control: max-age3600Expires: Sat, 31 Aug 2024 23:03:04 GMTLocatio html>head>title>301 Moved Permanently/title>/head>body>center>h1>301 Moved Permanently/h1>/center>hr>center>cloudflare/center>/body>/html>
Port 443
HTTP/1.1 200 OKDate: Sat, 31 Aug 2024 22:03:05 GMTContent-Type: text/html; charsetUTF-8Transfer-Encoding: chunkedConnection: keep-alivevary: Accept-EncodingCF-Cache-Status: DYNAMICSet-Cookie: __cf_bma !DOCTYPE HTML>html langen-US> head> meta charsetUTF-8/> title>Erivedge® (vismodegib) | Advanced Basal Cell Carcinoma (aBCC) Treatment/title> meta namedescription contentLearn about Erivedge® (vismodegib) as a basal cell carcinoma treatment option for both metastatic and locally advanced carcinoma. See full safety and Boxed Warning for more information./> meta nametemplate contentflexible-page/> meta nameviewport contentwidthdevice-width, initial-scale1/> link relcanonical hrefhttps://www.erivedge.com//> meta propertyog:site_name contenterivedge/> meta propertyog:type contentwebsite/> meta propertyog:locale contenten_US/> meta propertyog:title contentErivedge® (vismodegib) | Advanced Basal Cell Carcinoma (aBCC) Treatment/> meta propertyog:description contentLearn about Erivedge® (vismodegib) as a basal cell carcinoma treatment option for both metastatic and locally advanced carcinoma. See full safety and Boxed Warning for more information./> meta propertyog:url contenthttps://www.erivedge.com//> meta propertyog:image contenthttps://www.erivedge.com/content/dam/gene/erivedge/logos/erivedge-logo.genecoreimg.1200.svg/> meta propertyog:image:type contentimage/svg+xml/> meta propertyog:image:width content240/> meta propertyog:image:height content124/> meta propertyog:image:alt contentErivedge® (vismodegib) | Advanced Basal Cell Carcinoma (aBCC) Treatment/> meta nametwitter:card contentsummary_large_image/> meta namepub_date content2023-06-26T09:39:12-0700/> link relicon typeimage/x-icon href/content/dam/gene/erivedge/global/logos/favicon.ico/> link relshortcut icon typeimage/x-icon href/content/dam/gene/erivedge/global/logos/favicon.ico/> link hrefhttps://fonts.googleapis.com/css2?familyOpen+Sans:ital,wght@0,400;0,700;1,400;1,700&displayswap relstylesheet/> script typetext/plain classoptanon-category-C0002> window.NREUM||(NREUM{}),__nr_requirefunction(t,n,e){function r(e){if(!ne){var one{exports:{}};te0.c
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]